Task: Answer the multiple choice question.
Query: Which drug has a -40.457% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) C=CCNC(=S)NN=C1CCCCCCC1
b) Cc1cc(C)cc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
c) CNC(=O)/C(C#N)=C/c1cc(C)n(-c2ccc(N3CCOCC3)cc2)c1C
d) Brc1ccc2oc(-c3ccn[nH]3)cc2c1
Answer: b. Cc1cc(C)cc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)cc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
Cc1cc(C)cc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
N-(3,5-dimethylphenyl)-2-(3-pyrrolidin-1-ylquinoxalin-2-yl)sulfanylacetamide